Skip to Main content Skip to Navigation
Journal articles

Hyporientalin A, an anti-Candida peptaibol from a marine Trichoderma orientale

Abstract : A Trichoderma orientale strain LSBA1 was isolated from the Mediterranean marine sponge Cymbaxinella damicornis. The crude extract of T. orientale mycelium showed inhibitory activity against growth of Gram-positive and Gram-negative bacteria as well as clinical isolates of Candida albicans. Purification of the anti-Candida component was performed using a combination of open silica gel-60 column and reverse phase high performance liquid chromatography. The active compound called hyporientalin A has been identified as a peptaibol analogue of longibrachin-A-II using mass spectrometry. It exhibited fungicidal activity against clinical isolates of C. albicans with minimal inhibitory concentrations (MICs) ranging from 2.49 to 19.66 µM, comparable to that of the antifungal agent amphotericin B. Our data support the use of hyporientalin A as a promising new and efficient antifungal drug in the treatment of candidiasis while controlling toxicity.
Complete list of metadata
Contributor : Nicolas Ruiz Connect in order to contact the contributor
Submitted on : Thursday, August 25, 2022 - 3:28:45 PM
Last modification on : Saturday, August 27, 2022 - 3:52:40 AM



Ines Touati, Nicolas Ruiz, Olivier Thomas, Irina Druzhinina, Lea Atanasova, et al.. Hyporientalin A, an anti-Candida peptaibol from a marine Trichoderma orientale. World Journal of Microbiology and Biotechnology, Springer Verlag, 2018, 34 (7), pp.98. ⟨10.1007/s11274-018-2482-z⟩. ⟨hal-03596382⟩



Record views